Form 4 for NUVB Nuvation Bio Inc.
Accepted 2025-05-06 00:00:00 ET · period of report 2025-05-02 · accession 0001415889-25-012096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-06 | 2025-05-02 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $2.50 | -20.0K | 12.0K | -62% | -$50.0K |
| D | 2025-05-06 | 2025-05-02 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.94 | +20.0K | 32.0K | +167% | +$38.8K |
| D | 2025-05-06 | 2025-05-02 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.94 | -20.0K | 480.0K | -4% | -$38.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-02 | S | D | 20,000 | $2.50 | 12,000 | D | — | — | (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-05-02 | M | A | 20,000 | $1.94 | 32,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-05-02 | M | D | 20,000 | $1.94 | 480,000 | D | $1.94 · — to 2033-02-27 | 20,000 Class A Common Stock | (F3) Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date |